Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic × asparaginase erwinia chrysanthemi recombinant × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Leukemia 5 Leukemia, Myeloid, Acute 3 Recurrence 2 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoproliferative Disorders 1 Lymphoma 1 Leukemia, Biphenotypic, Acute 1 Immunoproliferative Disorders 1 Hypersensitivity 1 Down Syndrome 1

Interventions

fludarabine phosphate 20 Mycophenolic Acid 15 Whole-Body Irradiation 14 Peripheral Blood Stem Cell Transplantation 11 Cyclophosphamide 11 Cyclosporine 10 Cyclosporins 8 fludarabine 7 Tacrolimus 7 Rituximab 7 Antilymphocyte Serum 7 Busulfan 6 Sirolimus 4 Melphalan 4 Methotrexate 3 Cytarabine 3 Cord Blood Stem Cell Transplantation 3 pegfilgrastim 2 ibrutinib 2 Thiotepa 2 Oxaliplatin 2 Filgrastim 2 Etoposide 2 Darbepoetin alfa 2 thymoglobulin 1 selinexor 1 ofatumumab 1 immunotoxin HA22 1 ferrous sulfate 1 ferric gluconate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡